KINDRED BIOSCIENCES, INC.
CIK 0001561743
Revenue (TTM)
$46.54M
+890.7% YoY
Q2 Jul 2021
Net Income (TTM)
−$7.01M
−38.5% YoY
Q2 Jul 2021
EPS Diluted (TTM)
—
Q2 Jul 2021
Gross Margin
95.9%
Q2 Jul 2021
Operating Margin
-10.6%
Q2 Jul 2021
Net Margin
-15.1%
Q2 Jul 2021
Free Cash Flow (TTM)
−$61.14M
Q2 Jul 2021
Cash
$46.72M
Q2 Jul 2021
Total Debt
$20.8M
Q2 Jul 2021
Shares Outstanding
45.46M sh
Q2 Jul 2021